Search research articles
Contact Us
Filters
Showing results (101-110 of 199) with videos related to
Page
of 20
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
May 18, 2019
Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence
V Grøndahl, T Binderup, S W Langer, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 1, 1996
Brain relapses in chemotherapy-treated small cell lung cancer: a retrospective review of two time-dose regimens of therapeutic brain irradiation
F Bach, J B Sørensen, L Adrian, et al.
Diagnostics (Basel, Switzerland)
|
May 11, 2024
Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu/<sup>225</sup>AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas
Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, et al.
Ugeskrift for Laeger
|
March 15, 1993
[The value of bone marrow scintigraphy in patients with recurrent breast cancer]
S W Langer, C Kamby, H S Thomsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 18, 2022
Prospective Phase II Trial of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET/CT Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for Prognostication in Patients with Neuroendocrine Neoplasms
Esben Andreas Carlsen, Mathias Loft, Annika Loft, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 17, 2020
Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: A randomized clinical trial
Morten Quist, Seppo W Langer, Christian Lillelund, et al.
Journal of Neuroendocrinology
|
June 27, 2024
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms
H Sorbye, G O Hjortland, L W Vestermark, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2016
Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 Patients
Camilla B Johnbeck, Ulrich Knigge, Seppo W Langer, et al.
European Journal of Radiology
|
July 3, 2017
Treatment of multiple test readers in diagnostic accuracy systematic reviews-meta-analyses of imaging studies
Trevor A McGrath, Matthew D F McInnes, Felipe W Langer, et al.
BMC Cancer
|
January 12, 2020
P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
Kirstine Nielsen, Tina Binderup, Seppo W Langer, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 199) with videos related to
Sort By:
Page
of 20
Lung Cancer (Amsterdam, Netherlands)
|
May 18, 2019
Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence
V Grøndahl, T Binderup, S W Langer, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 1, 1996
Brain relapses in chemotherapy-treated small cell lung cancer: a retrospective review of two time-dose regimens of therapeutic brain irradiation
F Bach, J B Sørensen, L Adrian, et al.
Diagnostics (Basel, Switzerland)
|
May 11, 2024
Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu/<sup>225</sup>AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas
Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, et al.
Ugeskrift for Laeger
|
March 15, 1993
[The value of bone marrow scintigraphy in patients with recurrent breast cancer]
S W Langer, C Kamby, H S Thomsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 18, 2022
Prospective Phase II Trial of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET/CT Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for Prognostication in Patients with Neuroendocrine Neoplasms
Esben Andreas Carlsen, Mathias Loft, Annika Loft, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 17, 2020
Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: A randomized clinical trial
Morten Quist, Seppo W Langer, Christian Lillelund, et al.
Journal of Neuroendocrinology
|
June 27, 2024
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms
H Sorbye, G O Hjortland, L W Vestermark, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2016
Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 Patients
Camilla B Johnbeck, Ulrich Knigge, Seppo W Langer, et al.
European Journal of Radiology
|
July 3, 2017
Treatment of multiple test readers in diagnostic accuracy systematic reviews-meta-analyses of imaging studies
Trevor A McGrath, Matthew D F McInnes, Felipe W Langer, et al.
BMC Cancer
|
January 12, 2020
P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
Kirstine Nielsen, Tina Binderup, Seppo W Langer, et al.
Page
of 20